欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/H/0554/003
药品名称
BABIVEN G15
活性成分
valine 0.83 g/l
zinc acetate 6.72 mg/l
tyrosine 0.11 g/l
tryptophan 0.32 g/l
threonine 0.83 g/l
taurine 0.07 g/l
sodium chloride 1.75 g/l
sodium fluoride 1.11 mg/l
serine 0.87 g/l
proline 1.29 g/l
potassium chloride 0.67 g/l
potassium iodide 0.07 mg/l
potassium dipotassium phosphate 1.39 g/l
copper sulfate 1.18 mg/l
chromium(III)chloride 0.1 mg/l
calcium gluconate 2.69 g/l
aspartic acid 0.94 g/l
arginine 0.94 g/l
alanine 1.45 g/l
acetylcysteine 0.31 g/l
magnesium lactate 0.95 g/l
lysine monohydrate 1.45 g/l
leucine 1.61 g/l
isoleucine 0.71 g/l
histidine 0.48 g/l
glycine 0.48 g/l
glutamic acid 1.63 g/l
glucose monohydrate 165.0 g/l
ferrous sulphate 2.49 mg/l
methionine 0.3 g/l
manganese(II)chloride tetrahydrate 0.36 mg/l
phenylalanine 0.62 g/l
剂型
Solution for infusion
上市许可持有人
Fresenius Kabi France
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Belgium (BE)
Kidiamix
Netherlands (NL)
Austria (AT)
Pediaven Glucose 15% Infusionslösung
Spain (ES)
Portugal (PT)
Italy (IT)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Pediaven G15 infuzinis tirpalas
Estonia (EE)
PEDIAVEN G15
Hungary (HU)
许可日期
2014/05/05
最近更新日期
2020/01/21
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase